Related Articles
Mps1 is associated with the BRAFV600E mutation and predicts poor outcome in patients with colorectal cancer
Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
MPS1 kinase as a potential therapeutic target in medulloblastoma
Targeting Mps1 in combination with paclitaxel inhibits osteosarcoma progression by modulating spindle assembly checkpoint and Akt/mTOR signaling
Energy‑stress‑mediated activation of AMPK sensitizes MPS1 kinase inhibition in triple‑negative breast cancer